323. Aromatic L-amino acid decarboxylase deficiency Clinical trials / Disease details
Clinical trial : 1 / Drugs : 2 - (DrugBank : 1) / Drug target genes : 3 - Drug target pathways : 2
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05211609 (ClinicalTrials.gov) | May 1, 2022 | 17/12/2021 | Prevalence of High Plasmatic 3OMethyldopa Level in a Specific Population of Patients With a Symptomatology Compatible With AADC Deficiency | Prevalence of High Plasmatic 3-O-Methyldopa Level in a Specific Population of Patients With a Symptomatology Compatible With AADC Deficiency (Aromatic L-Amino Acid Decarboxylase) | Aromatic L-Amino Acid Decarboxylase Deficiency | Diagnostic Test: Plasmatic 3-O-Methyldopa dosage | University Hospital, Montpellier | NULL | Not yet recruiting | N/A | 65 Years | All | 388 | N/A | NULL |